Coronary angiography, n (%) | |
Normal | 76 (63.3) |
Parietal irregularities | 25 (20.9) |
Non-obstructed coronary lesions | 18 (15) |
Ectatic coronary arteries | 1 (0.8) |
Ventriculography | 33 (27.5) |
Cardiovascular magnetic resonance | |
LVEDVI (mL/m2), median (IQR) | 89.2 (70.8–119.2) |
LVESVI (mL/m2), median (IQR) | 40 (26.7–70.7) |
LVEF (%), median (IQR) | 54.8 (37–62) |
RVEDVI (mL/m2), median (IQR) | 70.1 (57.1–81.6) |
RVESVI (mL/m2), median (IQR) | 22.3 (17.8–35) |
RVEF (%), median (IQR) | 67 (57–68.9) |
LV mass index (g/m2), median (IQR) | 97.2 (83.8–157.6) |
Presence of late gadolinium enhancement, n (%) | |
Subendocardial | 19 (15.8) |
Transmural | 93 (77.5) |
Both | 8 (6.7) |
Myocardial segments with enhancement, n (%) | |
1 segment | 40 (33.3) |
2 segments | 43 (35.8) |
≥ 3 segments | 37 (30.9) |
Main infarct locations, n (%) | |
Inferolateral | 38 (31.7) |
2 affected myocardial territories | 9 (7.5) |
Right ventricle | 3 (2.5) |